title: In utero exposure to therapeutic radiation for Hodgkin lymphoma.
abstract: OBJECTIVE
  One of my patients was incidentally found to be pregnant after completion of radiotherapy for Hodgkin lymphoma. What are the possible effects that I should discuss with her before she makes a final decision regarding continuation of her pregnancy?
  
  
  CONCLUSIONS
  Radiotherapy might not be an absolute contraindication in pregnant women who are diagnosed with cancer located in areas remote from the pelvis. However, the fetal exposure should be carefully estimated, and the known dose-response information has to be discussed individually to allow informed decisions to be made.
authors.forename: Chagit
authors.initials: C
authors.lastname: Klieger-Grossmann
authors.forename: Nada
authors.initials: N
authors.lastname: Djokanovic
authors.forename: David
authors.initials: D
authors.lastname: Chitayat
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
mesh_terms: D000328:Adult; D002675:Child, Preschool; D005260:Female; D005333:Fetus / Q000528:radiation effects*; D006128:Growth / Q000528:radiation effects; D006689:Hodgkin Disease / Q000532:radiotherapy*; D006801:Humans; D033162:Incidental Findings; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000532:radiotherapy*; D011297:Prenatal Exposure Delayed Effects; D011879:Radiotherapy Dosage